Airway mucins are the major constituents of mucus and one of the first lines of host defense against inhaled pathogens. However, aberrant expression of mucins is associated with mucus hypersecretion resulting in chronic nasal drainage, a common complaint from patients with chronic rhinosinusitis (CRS). Our goal in this systematic review was to determine (1) expression profiles, (2) regulatory mechanisms, and (3) the pathologic roles of mucins associated with CRS.
Methods
MEDLINE, Cochrane Library, Embase, Scopus, Web of Science, and ClinicalTrials.gov were searched for studies focused on the role of mucins in CRS. Quality was assessed using the Cochrane Risk of Bias tool. The full text articles selected were then categorized into 3 study groups: (1) clinical, (2) animal, and (3) in vitro cultures. Data regarding study design, population/setting, methods, and bias were extracted and synthesized.
Results
Our initial search generated 392 titles/abstracts. After the primary review, 111 articles underwent secondary review. The final review included 53 articles, including 34 articles (64%) in the clinical study group, 3 articles (6%) in the animal study group, and 16 articles (30%) in the in vitro study group. In total, aberrant expression of 8 mucins—6 secreted-mucins (MUC2, -5AC, -5B, -6, -7, and -8) and 2 membrane-bound mucins (MUC1 and -4)—were identified in CRS tissues compared to healthy controls. Mucin expression was associated with bacterial sinusitis, inflammatory markers, and the response to steroid therapy in patients with CRS with nasal polyposis.
Conclusion
There is a strong correlation between alterations in mucin expression profiles and CRS. This systematic review highlights the most recent literature on the role of mucins in CRS. The analysis of these studies is limited by the heterogeneity in study designs, relatively few numbers of clinical samples, and lack of mechanistic studies in animal models and in vitro cultures.
BhattacharyyaNOrlandiRRGrebnerJMartinsonM.Cost burden of chronic rhinosinusitis: a claims-based study.Otolaryngol Head Neck Surg. 2011;
144(3):440–445.
2.
FahyJVDickeyBF.Airway mucus function and dysfunction.N Engl J Med. 2010;
363(23):2233–2247.
3.
ThorntonDJRousseauKMcGuckinMA.Structure and function of the polymeric mucins in airways mucus.Annu Rev Physiol. 2008;
70:459–486.
4.
HattrupCLGendlerSJ.Structure and function of the cell surface (tethered) mucins.Annu Rev Physiol. 2008;
70:431–457.
5.
VoynowJARubinBK.Mucins, mucus, and sputum.Chest. 2009;
135(2):505–512.
6.
BonserLRErleDJ.Airway mucus and asthma: the role of MUC5AC and MUC5B. J Clin Med. 2017;
6(12).
7.
MoherDLiberatiATetzlaffJAltmanDG, PRISMA Group.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Ann Intern Med. 2009;
151(4):264–269, W64.
8.
HigginsJPTGreenS, Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions.
Chichester, England:
Wiley-Blackwell; 2008:
xxi, 649 p.
9.
KatoKLillehojEPLuWKimKC.MUC1: the first respiratory mucin with an anti-inflammatory function. J Clin Med. 2017;
6(12).
10.
ThaiPLoukoianovAWachiSWuR.Regulation of airway mucin gene expression.Annu Rev Physiol. 2008;
70:405–429.
11.
PenaMTAujlaPKPatelKMZalzalGHRoseMC.Immunohistochemical analyses of MUC5AC mucin expression in sinus mucosa of children with sinusitis and controls.Ann Otol Rhinol Laryngol. 2005;
114(12):958–965.
12.
SaiegABrownKJPenaMTRoseMCPreciadoD.Proteomic analysis of pediatric sinonasal secretions shows increased MUC5B mucin in CRS.Pediatr Res. 2015;
77(2):356–362.
13.
WuXAmornMMAujlaPKet al.
Histologic characteristics and mucin immunohistochemistry of cystic fibrosis sinus mucosa.Arch Otolaryngol Head Neck Surg. 2011;
137(4):383–389.
14.
PenaMTAujlaPKZudaireEet al.
Localization and expression pediatric of MUC5B and MUC7 mucins in pediatric sinus mucosa.Ann Otol Rhinol Laryngol. 2007;
116(5):389–397.
15.
SymmesBAStefanskiALMaginCMEvansCM.Role of mucins in lung homeostasis: regulated expression and biosynthesis in health and disease.Biochem Soc Trans. 2018;
46(3):707–719.
16.
RoyMGLivraghi-ButricoAFletcherAAet al.
Muc5b is required for airway defence.Nature. 2014;
505(7483):412–416.
17.
AliMSHuttonDAWilsonJAPearsonJP.Major secretory mucin expression in chronic sinusitis.Otolaryngol Head Neck Surg. 2005;
133(3):423–428.
18.
BaiJMiaoBWuXet al.
Enhanced expression of SAM-pointed domain-containing Ets-like factor in chronic rhinosinusitis with nasal polyps.Laryngoscope. 2015;
125(3):E97–E103.
19.
BergerGKoganTOphirDSkutelskyEPitaroK.Glycoconjugate expression of sinus mucosa in chronic rhinosinusitis: a lectin histochemical study.Am J Rhinol. 2008;
22(4):349–355.
20.
DingGQZhengCQ.The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.Am J Rhinol. 2007;
21(3):359–366.
21.
DuJBaLLiBet al.
Distinct expression of NK2 homeobox 1 (NKX2-1) and goblet cell hyperplasia in nasal polyps with different endotypes.Int Forum Allergy Rhinol. 2017;
7(7):690–698.
22.
JungHHLeeJHKimYTLeeSDParkJH.Expression of mucin genes in chronic ethmoiditis.Am J Rhinol. 2000;
14(3):163–170.
23.
KimDHChuHSLeeJYHwangSJLeeSHLeeHM.Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis.Arch Otolaryngol Head Neck Surg. 2004;
130(6):747–752.
24.
KimHKKookJHKangKROhDJKimTHLeeSH.Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC.Laryngoscope. 2016;
126(11):E347–E355.
25.
LuoQZhangJWangHet al.
Expression and regulation of transcription factor FoxA2 in chronic rhinosinusitis with and without nasal polyps.Allergy Asthma Immunol Res. 2015;
7(5):458–466.
26.
LuoQZhangZLiuDFengKJinXZhangJ.Human neutrophil elastase induces MUC5AC overexpression in chronic rhinosinusitis through tumour necrosis factor-alpha converting enzyme.Acta Otolaryngol. 2016;
136(6):641–648.
27.
MaoYJChenHHWangBLiuXXiongGY.Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.Auris Nasus Larynx. 2015;
42(4):294–298.
28.
SeshadriSLuXPurkeyMRet al.
Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis.J Allergy Clin Immunol. 2015;
136(6):1548–1558.e7.
29.
XiaWTBaiJWuXMWeiYFengSYLiLet al.
Interleukin-17A promotes MUC5AC expression and goblet cell hyperplasia in nasal polyps via the Act1-mediated pathway. PLoS One. 2014;
9(6):e98915.
30.
Martinez-AntonAde BolosCAlobidIet al.
Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.Allergy. 2008;
63(10):1368–1376.
31.
Martinez-AntonADebolosCGarridoMet al.
Mucin genes have different expression patterns in healthy and diseased upper airway mucosa.Clin Exp Allergy. 2006;
36(4):448–457.
32.
SeongJKKooJSLeeWJet al.
Upregulation of MUC8 and downregulation of MUC5AC by inflammatory mediators in human nasal polyps and cultured nasal epithelium.Acta Otolaryngol. 2002;
122(4):401–407.
33.
ViswanathanHBrownleeIAPearsonJPCarrieS.MUC5B secretion is up-regulated in sinusitis compared with controls.Am J Rhinol. 2006;
20(5):554–557.
34.
LässerCO’NeilSSihlbomCHanssonSLundbäckBLötvallJ.The proteome of nasal exosomes in healthy, asthmatic and chronic rhinosinusitis subjects: a quantitative proteomics approach. Eur J Allergy Clin Immunol. 2012;
67:590.
35.
Al BadaaiYDiFalcoMRTewfikMASamahaM. Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis. J Otolaryngol Head Neck Surg. 2009;
38(3):381–389.
36.
McGuckinMALindenSKSuttonPFlorinTH.Mucin dynamics and enteric pathogens.Nat Rev Microbiol. 2011;
9(4):265–278.
37.
Xue-KunHYuanLJinYPengLHongL.Expression of MUC2 and MUC5B in ethmoid sinus mucosa of patients with chronic rhinosinusitis. Sci Res Essays. 2010;
5(13):1690–1696.
38.
KimSSKimKSLeeJGParkIYKooJSYoonJH.Levels of intracellular protein and messenger RNA of mucin and lysozyme in normal human nasal and polyp epithelium.Laryngoscope. 2000;
110(2 Pt 1):276–280.
39.
TakeuchiKYutaASakakuraY.MUC2 mucin gene expression in the nose and maxillary sinus.Am J Otolaryngol. 1995;
16(6):391–395.
40.
LasserCO’NeilSEShelkeGVet al.
Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation. J Transl Med. 2016;
14(1):181.
VoynowJASelbyDMRoseMC.Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals.Lung. 1998;
176(5):345–354.
43.
AliMSWilsonJAPearsonJP.Mixed nasal mucus as a model for sinus mucin gene expression studies.Laryngoscope. 2002;
112(2):326–331.
44.
TanLPsaltisABakerLMMcGuckinMRousseauKWormaldPJ.Aberrant mucin glycoprotein patterns of chronic rhinosinusitis patients with bacterial biofilms.Am J Rhinol Allergy. 2010;
24(5):319–324.
45.
KimCHSongKSKimSSKimHUSeongJKYoonJH.Expression of MUC5AC mRNA in the goblet cells of human nasal mucosa.Laryngoscope. 2000;
110(12):2110–2113.
46.
AlenmyrLHerrmannAHogestattEDGreiffLZygmuntPM.TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo.Clin Physiol Funct Imaging. 2011;
31(6):435–444.
47.
MilaraJMorellABallesterBArmengotMMorcilloECortijoJ.MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps.J Allergy Clin Immunol. 2017;
139(3): 855–862.e13.
48.
MilaraJPeiroTArmengotMet al.
Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps.J Allergy Clin Immunol. 2015;
135(2):470–476.
49.
DingGQZhengCQBaggaSS.Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis.Arch Otolaryngol Head Neck Surg. 2007;
133(11):1097–1103.
50.
BaiCHSongSYKimYD.Effect of glucocorticoid on the MUC4 gene in nasal polyps.Laryngoscope. 2007;
117(12):2169–2173.
51.
JiaoJDuanSMengNLiYFanEZhangL.Role of IFN-gamma, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps.Clin Exp Allergy. 2016;
46(3):449–460.
52.
ZhangYWangXWangHet al.
TMEM16A-mediated mucin secretion in IL-13-induced nasal epithelial cells from chronic rhinosinusitis patients.Allergy Asthma Immunol Res. 2015;
7(4):367–375.
53.
SongSYWooHJBaeCHKimYWKimYD.Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue.Laryngoscope. 2010;
120(5):1046–1050.
54.
IshinagaHKitanoMTodaMet al.
Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells.Cytokine. 2017;
90:60–65.
55.
KimYJChoHJShinWCSongHAYoonJHKimCH.Hypoxia-mediated mechanism of MUC5AC production in human nasal epithelia and its implication in rhinosinusitis. PLoS One. 2014;
9(5):e98136.
56.
SongSYSeoYJKimYWParkSYBaeCHKimYD.Effect of Onchocerca volvulus chitinase on MUC5B expression in human airway epithelial cells.Am J Rhinol Allergy. 2013;
27(1):3–7.
57.
WangWWShaoSWWangS.The role for human nasal epithelial nuclear factor kappa B activation in histamine-induced mucin 5 subtype B overproduction.Int Forum Allergy Rhinol. 2016;
6(3):264–270.
58.
ShinSHYeMKKimJK.Effects of fungi and eosinophils on mucin gene expression in rhinovirus-infected nasal epithelial cells.Allergy Asthma Immunol Res. 2014;
6(2):149–155.
59.
KimHJKimCHRyuJHet al.
Crosstalk between platelet-derived growth factor-induced Nox4 activation and MUC8 gene overexpression in human airway epithelial cells.Free Radic Biol Med. 2011;
50(9):1039–1052.
60.
SongKSSeongJKChungKCet al.
Induction of MUC8 gene expression by interleukin-1 beta is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells.J Biol Chem. 2003;
278(37):34890–34896.
61.
HauberHPDaigneaultPFrenkielSet al.
Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa.J Allergy Clin Immunol. 2005;
115(2):266–271.
62.
SudhoffHKlenkeCGreinerJFet al.
1,8-Cineol reduces mucus-production in a novel human ex vivo model of late rhinosinusitis.PLoS One. 2015;
10(7):e0133040.
63.
NoyamaYOkanoMFujiwaraTet al.
IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression.Allergol Int. 2017;
66(1):42–51.
BernsteinJMLehmanHLisMet al.
Humanized mouse model used to monitor MUC gene expression in nasal polyps and to preclinically evaluate the efficacy of montelukast in reducing mucus production.Ann Otol Rhinol Laryngol. 2012;
121(5):307–316.
66.
ChoHYHotchkissJAHarkemaJR.Inflammatory and epithelial responses during the development of ozone-induced mucous cell metaplasia in the nasal epithelium of rats.Toxicol Sci. 1999;
51(1):135–145.
AliMES.Nasosinus mucin expression in normal and inflammatory conditions.Curr Opin Allergy Clin Immunol. 2009;
9(1):10–15.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
